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expression, followed by a delayed dose-dependent increase (20h-40h).
Cyp1A1 mRNA expression was synergistically stimulated by TCDD and IL-
1B treatment,. BaP exerted similar effects on Cyp1A1 expression while the
AhR antagonist alpha-naphthoﬂavone (aNF) suppressed the TCDD part of
Cyp1A1 induction but not that of IL-1B. Conversely, AhR ligands synergized
with IL1-B and clearly increased the amount of IL-1B mRNA, but only
moderately that of IL1-RA mRNA.
Conclusions: Cartilage appears as a target for persistent environmental
pollutants acting as aggravating pro-inﬂammatory factors through the AhR.
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CYCLICAL HYPEROSMOLAR LOADING OF HUMAN ARTICULAR
CHONDROCYTES INCREASES SOX9 GENE EXPRESSION AND P38
SIGNALLING IS REQUIRED
M.J. Peffers, P.D. Clegg, S. Tew, P.I. Milne
Univ. of Liverpool, Neston, United Kingdom
Purpose: SOX9 is a transcription factor required for cartilage formation
and is essential for cartilage extracellular matrix formation (ECM). Os-
teoarthritis (OA) is characterized by a loss of ECM. In human aged OA
cartilage SOX9 gene expression is regulated by osmotic loading. Here we
characterise SOX9 mRNA regulation through cyclical application of human
articular chondrocytes (HAC). The role of the p38 MAPK pathway was
investigated using pharmacological inhibition to identify mechanisms of
SOX9 regulation.
Methods: Cartilage was obtained following total knee arthroplasty with
informed consent and ethical approval. Cultures of freshly isolated HAC
were used in experiments within 24 hours. Osmotic load was either static
or cyclical, where loads were applied by incubating cells for 5 hours in
380 and 550mOsm medium alternating every 30 or 60 minutes, containing
either DMSO, or 20μM p38 MAP kinase inhibitor SB202190. Reverse tran-
scription and quantitative real-time PCR was used to measure the levels
of SOX9, Aggrecan and COL2A1 mRNA. Western blots were probed with
antibodies recognising phospho p38, SOX9, total ERK or GAPDH. Statistical
analysis was performed using mixed effects regression models.
Results: Static hyperosmotic loading for 5 hours signiﬁcantly increased
SOX9 mRNA in freshly isolated HAC; 2.5 fold, p=0.0027. Further experi-
ments investigated how the nature of the osmotic load applied to cells
effected SOX9 expression. In vivo, chondrocytes are subjected to periods
of cyclical loading which will generate ﬂuid ﬂow and osmotic ﬂuctuations
within the tissue. Cyclical loading between 380 and 550mOsm increased
SOX9 to a greater extent than cycling at the same osmolarity. This was
signiﬁcant at both 30 and 60 minute frequencies; 2.5 fold; p=0.001, 2.9 fold
p=0.0009 (Fig. 1).
Figure 1
Western blot analysis using a phosphorylated p38 MAPK speciﬁc antibody
identiﬁed an increase in activation of p38 MAPK at 550mOsm under static
hyperosmolar conditions. Cyclical hyperosmolar loading every 60 minutes
led to an increase in p38 MAPK activation compared to control (Fig. 2a).
In addition p38 MAPK inhibition caused a reduction in SOX9 protein in all
conditions (Fig. 2b). There was also a signiﬁcant decrease in SOX9 mRNA at
c30 and c60 conditions; p=0.001, p=0.003.
Finally we looked at the gene expression of COL2A1 and Aggrecan and
found that application of static hyperosmotic conditions for a 5 hour
period resulted in a signiﬁcant decrease in Aggrecan and COL2A1 mRNA;
Figure 2
p=0.0012, p=0.0008 respectively. No effects were evident during cyclical
hyperosmolar loading.
Conclusions: The regulation of SOX9 in chondrocytes is beginning to be
identiﬁed. One mechanism is through p38 MAPK-dependant signalling
leading to post-transcriptional stabilisation of its mRNA. Furthermore
medium osmolarity, a known regulator of p38 MAPK, controls SOX9 by
this mechanism. We identiﬁed that SOX9 is upregulated by both static and
dynamic hyperosmotic conditions. Whilst these conditions are not meant
to precisely simulate the osmotic conditions experienced by a chondrocyte
in vivo, they do demonstrate that repeated applications of these stimuli can
enhance their production of factors such as SOX9.
We examined Aggrecan and COL2A1 mRNA levels. Although there was no
apparent change in mRNA in cyclical loading of HAC, static hyperosmolar
loading caused a reduction in their expression agreeing with the majority
of studies that have noted a decrease in ECM production under static
hyperosmotic loading.
Understanding the regulation of SOX9 could lead to novel strategies to
improve techniques of cartilage repair
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Systems Biology Approach and High-throughput Proteomic Analysis
Identiﬁes Toll-Like-Receptor Activators as Major Players of Cartilage
Degeneration
L. Alexopoulos1 , A. Chairakaki1,2, I. Melas1, C. Provatidis1, P. Kolia2,
Z. Dailiana3
1Natl. Technical Univ. of Athens, Athens, Greece; 2Univ. of Athens, Athens,
Greece; 3Univ. of Thessaly, Larissa, Greece
Purpose: The goal of this study is to combine biomechanical and sys-
tems biology approaches to reveal major players of cartilage degeneration.
Cartilage degeneration can be characterized by the imbalance of a com-
plex intracellular network orchestrated by several regulatory proteins.
IL-1α and TNF-α are two well known cytokines responsible for cartilage
degeneration but there are possibly several other pro-catabolic stimuli
equally important but less studied. This project utilizes a multidisci-
plinary approach characterized by the fusion of two seemingly different
areas: Biomechanics and Systems Biology. Systems biology approach has
been used for a “functional” screen of 90 different stimuli. Speciﬁcally,
high-throughput proteomic measurements and computational algorithms
have been used to interrogate the intracellular and extracellular activity
of primary human chondrocytes treated with a large number of stimuli
ranging from interleukins, growth factors, chemokines, toll like receptor
(TLR) activators and other inﬂammatory stimuli. Computational models
such as partial least square, principal component analysis, clustering, and
integer linear programming have been employed to create signaling path-
ways, correlate signaling activity, and identify major catabolic stimuli. To
further conﬁrm the results biomechanical approaches (indentation tests)
have are been used to monitor the degradation of cartilage explants by
measuring alterations on the mechanical properties (Young’s modulus and
the permeability). The multidisciplinary approach of the project sheds
light into the molecular pathways that govern cartilage degeneration in an
unbiased way. Several TLR activators as well as other cytokines show major
catabolic role in cartilage that can be proved equally important as IL-1 and
TNFα.
Methods: Systems Biology approach: Chondrocytes were isolated from hu-
man femoral heads following standard isolation procedures. Cells were
plated in 96 well plates at 35,000 cells per well, stimulated by 90 dif-
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ferent cytokines at saturated concentrations and then incubated for up to
24 hours. Lysates and supernatants were collected and intracellular and
extracellular signals were measured using a high throughput method of
bead-based ﬂuorescent readings (Luminex xMAP assay, Austin, TX). For
each treatment 18 different phosphoprotein signals was measured includ-
ing p-AKT, p-MEK, p-ERK, p-p38, p-IκB at 10 and 25 minutes post-stimuli.
At 24 hours supernatants were collected and approximately 60 different
proteins including cytokines and metalloproteinases (MMPs) were mea-
sured. Data were normalized and plotted using custom software based on
the DataRail toolbox and subsequent analysis was performed using PLSR,
PCA, and clustering algorithms that have developed previously.
Results: IL1α, IL1β, and TNFα showed a signiﬁcant release of several pro-
catabolic proteins such as MMP1 and MMP13 but also pro-inﬂammatory
cytokines such as GROα, MCP1, MIP1α, and MIP1β. Interestingly, clustering
analysis revealed a number of TLR stimuli such as LPS and POLY I:C to
behave on a similar manner. Closer look into the phosphoprotein activity of
those proteins showed they act via the NFκB and possibly via the p38 path-
ways. Follow up experiment using selective p38 and IκB inhibitors proved
the pro-catabolic response of chondrocytes triggered by TLR agonists is
NFκB dependant.
Conclusions: “Functional” screens based on intracellular and extracellular
activities revealed that chondrocytes respond to a large number of stimuli
that has not been well characterized. TLR stimuli showed a behavior similar
to IL1α and TNFα. Upon TLR stimuli, chondrocytes shows an “immune-cell”
phenotype by releasing MMPs and several pro-catabolic and inﬂammaroty
cytokines via the NFκB pathway.
Clinical Aspects and Outcomes
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CLINICAL COMORBIDITIES, PAIN-RELATED PHARMACOTHERAPY, AND
DIRECT MEDICAL COSTS OF PATIENTS WITH OSTEOARTHRITIS IN
CLINICAL PRACTICE
M. Gore1, A. Sadosky2, K.-S. Tai1, D.L. Leslie3, B.R. Stacey4
1Avalon Hlth.Solutions, Inc., Philadelphia, PA; 2Pﬁzer, Inc., New York, NY;
3Penn State Coll. of Med., Hershey, PA; 4Oregon Hlth.& Sci. Univ., Portland, OR
Purpose: To examine comorbidities, pain-related pharmacotherapy, health
service use and direct medical costs of patients with osteoarthritis (OA) in
clinical practice.
Methods: This study was a retrospective cohort analysis based on a med-
ical and pharmacy claims database. Using the PharMetrics® Database, OA
patients (International Classiﬁcation of Diseases, Ninth Revision, Clinical
Modiﬁcation codes 715.XX) were identiﬁed and matched (age, gender, and
region) with a Control group of individuals without OA. Clinical comorbidi-
ties, pain-related pharmacotherapy, and health service use/direct medical
costs (pharmacy, outpatient, inpatient, total) were then examined during
the calendar year 2008.
Results: A total of 112,951 patients with OA satisﬁed all the study entry
criteria and were matched to 112,951 Controls without OA (mean age:
56.9±9.5 years; 62% female). Relative to Controls, OA patients were sig-
niﬁcantly more likely (p<0.0001) to have various comorbidities, including
musculoskeletal (84.3% versus 37.1%) and neuropathic pain (22.0% versus
6.1%) conditions, depression (12.4% versus 6.4%), anxiety (6.6% versus 3.5%),
and sleep disorders (11.9% versus 4.2%). OA patients were signiﬁcantly
more likely (p<0.0001) to receive pain-related medications, including opi-
oids (40.7% versus 17.1%), NSAIDs (37.1% versus 11.5%), tramadol (9.8%
versus 1.8), and prescription acetaminophen (1.3% versus 0.8%) relative to
Controls. OA patients were also signiﬁcantly more likely (p<0.0001) to be
prescribed “adjunctive” medications for treating conditions associated with
pain including depression, anxiety, and insomnia (antidepressants, 21.5%
versus 15.7%; benzodiazepines, 13.6% versus 9.1%; sedative/hypnotics, 9.6%
versus 5.3%). Use of healthcare resources including hospitalizations, emer-
gency room, physician oﬃce, and outpatient visits was signiﬁcantly higher
(p<0.0001) among OA patients relative to Controls; a majority of OA
patients (88% versus. 51% of Controls) had ≥4 physician oﬃce visits;
OA patients averaged 22 outpatient visits (versus 9 in Controls); over
13% of OA patients underwent OA-related surgeries; and 34% received
intra-articular injections during 2008. Relative to Controls, mean [SD] total
direct medical costs during 2008 were more than two times higher among
OA patients ($12,905 [$21,884] versus $5,099 [$13,855]; p < 0.001) and
median costs were more than three times higher ($6,188 versus $1,879);
p<0.0001.
Conclusions: The payer burden associated with OA was substantial,
evidenced by signiﬁcantly greater use of pain-related and adjunctive med-
ications and higher health service utilization and direct medical costs.
The patient burden, characterized by the higher prevalence of various
comorbidities was also substantial.
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CARTILAGE LOSS AND PAIN ARE INDEPENDENT RISK FACTORS IN THE
EVOLUTION OF EROSIVE HAND OSTEOARTHRITIS
J. Bijsterbosch, J.M. van Bemmel, I. Watt, I. Meulenbelt, F.R. Rosendaal,
T.W. Huizinga, M. Kloppenburg
Leiden Univ. Med. Ctr., Leiden, Netherlands
Purpose: Erosive hand osteoarthritis (EOA) is considered a subset of hand
osteoarthritis (OA) affecting mainly the interphalangeal (IP) joints. Because
little is known about its etiology, we evaluated potential risk factors for the
evolution of EOA.
Methods: Hand radiographs of 236 hand OA patients (mean age 59 yrs, 83%
women) participating in the Genetics, ARthrosis and Progression (GARP)
study were obtained at baseline and after six years. Hand OA was deﬁned
by the ACR criteria for clinical hand OA or the presence of structural
abnormalities (nodes/radiographic OA). Evolution in anatomical phase of IP
joints according to the Verbruggen-Veys system was assessed by scoring
paired radiographs in chronological order. In every IP joint the presence of
self-reported pain and stiffness (using a diagram including all IP joints), the
presence of pain on joint pressure and the presence of nodes was evaluated
at baseline. In addition, osteophytes and joint space narrowing (JSN) were
scored using the OARSI atlas. At the patient level, pain and functional
limitations were assessed with the Australian/Canadian Osteoarthritis Hand
Index (AUSCAN). Baseline HsCRP levels and innate cytokine production
(interleukin (IL)-1β, IL-1β receptor antagonist, IL-10 and tumor necrosis
factor-α) were included to reﬂect systemic inﬂammation and its predis-
position. Risk factors for the evolution of non-EOA IP joints to EOA and
for the evolution of active erosions to remodeling were assessed using
Generalized Estimating Equations (GEE) to take into account intra-patient
correlation.
Results: At baseline and follow-up 203 (4.7%) and 315 (7.4%) respectively
of the 4232 IP joints were classiﬁed as EOA. Non-EOA was present in 1487
(35%) at baseline and 1530 (36%) IP joints at follow-up. The remaining IP
joints were classiﬁed as normal. Of the 1487 non-EOA IP joints at baseline
97 (6.5%) progressed to EOA. Clinical and radiographic risk factors for this
evolution are shown in the table. Of the 91 IP joints with active erosions
at baseline 69 (76%) became remodeled. The presence of self-reported pain
was an independent risk factor for this ongoing erosive evolution (OR
(95%CI) 3.52 (1.08, 11.46)). Systemic inﬂammation was not associated with
either of the processes.
Table 1. Association between evolution of non-EOA to EOA and baseline characteristics
OR (95% CI)* OR (95% CI)**
Joint level
Self-reported pain 3.87 (2.40, 6.22) 2.01 (1.12, 3.63)
Self-reported stiffness 2.65 (1.49, 4.71) 1.68 (0.83, 3.40)
Pain on pressure 3.70 (2.37, 5.77) 1.52 (0.87, 2.65)
Node 3.22 (1.85, 5.63) 1.76 (0.86, 3.59)
Osteophyte grade 2-3 1.20 (0.38, 3.72) –
JSN grade 2-3 15.32 (9.16, 25.61) 13.29 (7.81, 22.64)
Patient level
AUSCAN pain 1.10 (1.04, 1.17) 1.04 (0.93, 1.16)
AUSCAN function 1.06 (1.02, 1.09) 0.99 (0.93, 1.05)
*Adjusted for age, sex, BMI; **Adjusted for variables associated in ﬁrst analysis and for
age, sex, BMI.
Conclusions: JSN was an independent risk factor for the evolution to
EOA, implying that local processes involved in cartilage loss may play a
role in the development of EOA. Pain was an independent risk factor for
the evolution to EOA as well as for the ongoing erosive process, which
may suggest a role for local inﬂammation. Further investigation on these
premises in longitudinal ultrasound or MRI studies is needed.
